Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M-Strong 4F is a branded generic fixed-dose combination product marketed by Lloyd Healthcare in India, specifically positioned within their orthopedic and musculoskeletal portfolio. While the exact formulation details are not explicitly detailed on the manufacturer's primary marketing page, products in the M-Strong series typically focus on neurotrophic and musculoskeletal support. The '4F' designation often refers to a combination of four active ingredients, which in the context of Indian orthopedic supplements for joint health, frequently includes components such as Glucosamine, Chondroitin, Methylsulfonylmethane (MSM), and Vitamin D3 or specialized extracts like Rosehip. It is used as a supportive therapy for conditions like osteoarthritis and other degenerative joint disorders to improve mobility and reduce inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on M-Strong 4F.